US4579852082
US4579852082
Integra LifeSciences Holdings C
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.635.245.000 | 1.610.527.000 | 1.5% |
| Cost of Revenue | 803.625.000 | 728.466.000 | 10.3% |
| Gross Profit | 831.620.000 | 882.061.000 | 5.7% |
| 813.625.000 | 853.650.000 | 4.7% | |
| Operating Income | 17.995.000 | 28.411.000 | 36.7% |
| Pretax Income | -563.502.000 | -18.237.000 | 2989.9% |
| Net Income Common Stockholders | -516.474.000 | -6.944.000 | 7337.7% |
| -- | -- | -- | |
| -- | -- | -- |